Back to Search
Start Over
Bergenia pacumbis from Nepal, an astonishing enzymes inhibitor.
- Source :
-
BMC complementary medicine and therapies [BMC Complement Med Ther] 2020 Jun 26; Vol. 20 (1), pp. 198. Date of Electronic Publication: 2020 Jun 26. - Publication Year :
- 2020
-
Abstract
- Background: The Bergenia species are perennial herbs native to central Asia, and one of the most promising medicinal plants of the family Saxifragaceae which are popularly known as 'Pashanbheda'. The aim of this study was to evaluate antioxidant and α-amylase, α-glucosidase, lipase, tyrosinase, elastase, and cholinesterases inhibition potential of Bergenia pacumbis of Nepali origin collected from the Karnali region of Nepal.<br />Methods: The sequential crude extracts were made in hexane, ethyl acetate, methanol, and water. Antioxidant activities were analyzed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay. The α-amylase, α-glucosidase, lipase, tyrosinase, elastase, acetylcholinesterase, and butyrylcholinesterase inhibition were analyzed by the 3,5-Dinitrosalicylic acid (DNSA), p-Nitrophenyl-α-D-glucopyranoside (p-NPG), 4-nitrophenyl butyrate (p-NPB), l-3,4-dihydroxyphenylalanine (L-DOPA), N-Succinyl-Ala-Ala-p-nitroanilide (AAAPVN), acetylthiocholine, and butyrylcholine as a respective substrate. The major metabolites were identified by high performance liquid chromatography with electron spray ionization- quadrupole time-of-flight mass spectrometry (HPLC-ESI-QTOF-MS) profiling.<br />Results: Our results revealed the great antioxidant ability of crude extract of B. pacumbis in ethyl acetate extract against both DPPH (IC <subscript>50</subscript> = 30.14 ± 0.14 μg/mL) and ABTS (IC <subscript>50</subscript> = 17.38 ± 1.12 μg/mL). However, the crude methanol extract of B. pacumbis showed the comparable enzymes inhibitions with standard drugs; α-amylase (IC <subscript>50</subscript> = 14.03 ± 0.04 μg/mL), α-glucosidase (IC <subscript>50</subscript> = 0.29 ± 0.00 μg/mL), lipase (IC <subscript>50</subscript> = 67.26 ± 0.17 μg/mL), tyrosinase (IC <subscript>50</subscript> = 58.25 ± 1.63 μg/mL), elastase (IC <subscript>50</subscript> = 74.00 ± 3.03 μg/mL), acetylcholinesterase (IC <subscript>50</subscript> = 31.52 ± 0.58 μg/mL), and butyrylcholinesterase (IC <subscript>50</subscript> = 11.69 ± 0.14 μg/mL). On the basis of HPLC-ESI-QTOF-MS profiling of metabolites, we identified major compounds such as Bergenin, Catechin, Arbutin, Gallic acid, Protocatechuic acid, Syringic acid, Hyperoside, Afzelechin, Methyl gallate, Paashaanolactone, Astilbin, Quercetin, Kaempferol-7-O-glucoside, Diosmetin, Phloretin, and Morin in methanol extract which has reported beneficial bioactivities.<br />Conclusion: Our study provides a plethora of scientific evidence that the crude extracts of B. pacumbis from Nepalese origin in different extracting solvents have shown significant potential on inhibiting free radicals as well as enzymes involved in digestion, skin related problems, and neurological disorders compared with the commercially available drugs.
- Subjects :
- Antioxidants chemistry
Cholinesterases metabolism
Enzyme Inhibitors chemistry
Lipase metabolism
Molecular Structure
Monophenol Monooxygenase metabolism
Nepal
Pancreatic Elastase metabolism
Plant Extracts chemistry
alpha-Amylases metabolism
alpha-Glucosidases metabolism
Antioxidants pharmacology
Enzyme Inhibitors pharmacology
Plant Extracts pharmacology
Saxifragaceae chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 2662-7671
- Volume :
- 20
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC complementary medicine and therapies
- Publication Type :
- Academic Journal
- Accession number :
- 32586304
- Full Text :
- https://doi.org/10.1186/s12906-020-02989-2